STEVEN MARK BETTAG MD NPI 1669529608

NPI Information

  • NPI: 1669529608
  • Provider Name: STEVEN MARK BETTAG, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1621 N TAYLOR DR
    SHEBOYGAN, WI
    ZIP 53081
  • Phone: (920) 458-7433

Map and Directions

Get Directions

NPI Details

Steven Mark Bettag, MD is a medical oncology internal medicine in Sheboygan, WI with 37 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Steven Mark Bettag, MD NPI is 1669529608. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Graduation Year:1989

The provider's business location address is:

1621 N TAYLOR DR
SHEBOYGAN, WI
ZIP 53081-990
Phone: (920) 458-7433
Fax: (920) 452-3594

The NPI 1669529608 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tbo-filgrastim, 1 microgram (HCPCS:J1447)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Unclassified drugs (HCPCS:J3490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Magnesium level (HCPCS:83735)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Blood test, clotting time (HCPCS:85610)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Vitamin d-3 level (HCPCS:82306)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
  • Phosphate level (HCPCS:84100)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Hemoglobin a1c level (HCPCS:83036)
  • Bilirubin level, direct (HCPCS:82248)
  • Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)

The enumeration date for this NPI number is 1/4/2007 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology36813-020WISCONSINYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
132158500MEDICAIDWISCONSIN
2F88849MEDICARE UPIN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.